Pfizer’s (NYSE: PFE) RSV Vaccine Proves Effective for Immuno-Compromised Adults in Study
On Monday, Pfizer (NYSE: PFE) said its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a […]
Pfizer’s (NYSE: PFE) RSV Vaccine Proves Effective for Immuno-Compromised Adults in Study Read More »